New requirements for medicine registration in the EU will improve global data exchange between pharmaceutical companies and regulators
June 14, 2021
January 15, 2021
2021 EAEU regulatory changes
Are you ready for 2021 EAEU regulatory changes?
Effective as of January 10, 2021, the registration of medicines in the Russian Federation carries out only in accordance with EAEU rules (Decision of the EEC Council No. 128 of December 23, 2020).
For other EAEU countries, the registration of medicines under national procedures has been extended until July 1, 2021.
Inpharmatis is an international consulting company with more than 15 years’ experience in EAEU, CIS, and EU markets in the field of regulatory services for pharmaceutical companies.
If you want to find out more information about EAEU registration rules, please contact us at info@inpharmatis.com.
Новые требования к подаче сведений при регистрации лекарственных средств в Евросоюзе улучшат глобальный обмен данными между фармкомпаниями и регуляторами
June 10, 2021
Inpharmatis принял участие в работе ПМЭФ-2021
June 04, 2021
Ольга Звонарева возглавит в Inpharmatis направление Regulatory Affairs в России и странах СНГ
May 31, 2021
Inpharmatis appoints new RA Director in Russia & CIS
May 31, 2021
Приведение досье в соответствие с правилами ЕАЭС
May 27, 2021
Bringing the dossier in accordance with the rules of the EAEU
May 27, 2021
Inpharmatis и «АКАДЕМФАРМ» обсудили в Минске перспективы сотрудничества
May 21, 2021
Inpharmatis and “ACADEMPHARM” discussed in Minsk cooperation opportunities
May 21, 2021
Participation in IPhEB Russia 2021
April 19, 2021